Although erythropoietin may have a role in the management of RBV-related anaemia, a recent study by Shiffman et al. failed to show an improvement in SVR in genotype 1-infected patients given epoetin alpha at the initiation of therapy to maintain haemoglobin levels between 12 and 15 g/dL [9]. The gene discussed is EPO; the disease is anemia.